晚期恶性黑色素瘤的治疗研究现状与进展  

Therapy for Advanced Malignant Melanoma: Current Research Status and Progress

作　　者：贺蓝鑫 马金华[2] 

机构地区：[1]青海大学研究生院,青海 西宁 [2]青海大学附属医院肿瘤内科,青海 西宁

出　　处：《临床个性化医学》2024年第2期256-262,共7页Journal of Clinical Personalized Medicine

摘　　要：作为全球患者人数增长最快的恶性肿瘤之一,恶性黑色素瘤的发病机制尚不清晰,其往往容易发生远处转移、扩散,而治疗晚期恶性黑色素瘤患者的手段有限,预后往往是不理想。近些年,得益于免疫学以及肿瘤生物学等前沿学科的迅速发展,黑色素瘤的治疗进入一个新的阶段,尤其是免疫和靶向治疗这一利器的出现与进展,使晚期黑色素瘤患者的生存率有所上升,但仍需要我们继续探索。本文作者就近年来对该病治疗研究现状与进展作如下综述。As one of the fastest growing malignant tumors in the world, the pathogenesis of malignant melanoma is not clear, and it is often prone to distant metastasis and spread, the means in the treatment of advanced malignant melanoma are limited, the prognosis is often not ideal. In recent years, because of the rapid development of immunology and tumor biology, the treatment of melanoma has entered a new stage, especially the appearance and progress of immunology and targeted therapy, the survival rate of patients with advanced melanoma has increased, but we still need to continue to explore. This article reviews the current status and progress in the treatment of this disease in recent years.

关 键 词：晚期恶性黑色素瘤 靶向治疗 免疫治疗 化疗 手术治疗 

分 类 号：R73[医药卫生—肿瘤]